Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Abroad (travel likely)RecruitingPHASE2

Conditions

Solid Tumors · Children · Adolescent · Chemotherapy Induced Neutropenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
Contact: Study coordinator (Sidan Li) · lisidan2006@126.com · +86-010-87788559

Study leads

Sidan Li
Principal Investigator
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Advanced Solid Tumors With MAPK Pathway Mutations

Abroad (travel likely)RecruitingPHASE1, PHASE2

Detroit, United States · New York, United States

Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors

Solid Tumor · Advanced Cancer

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Guiyang, China

A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Advanced Solid Tumors · Breast Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hefei, China · Fuzhou, China

A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.

Patients with Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China